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Context: Gender differences in mental disorders, in-
cluding more anxiety and mood disorders among women
and more externalizing disorders among men, are found
consistently in epidemiological surveys. The gender roles
hypothesis suggests that these differences narrow as the
roles of women and men become more equal.
Objectives: To study time-space (cohort-country) varia-
tion in gender differences in lifetimeDSM-IVmental dis-
orders across cohorts in 15 countries in the World Health
Organization World Mental Health Survey Initiative and
to determine if this variation is significantly related to
time-space variation in female gender role traditionality
as measured by aggregate patterns of female education,
employment, marital timing, and use of birth control.
Design: Face-to-face household surveys.
Setting: Africa, the Americas, Asia, Europe, the Middle
East, and the Pacific.
Participants: Community-dwelling adults (N=72 933).
Main Outcome Measures: The World Health Orga-
nization Composite International Diagnostic Interview
assessed lifetime prevalence and age at onset of 18DSM-IV
anxiety, mood, externalizing, and substance disorders.
Survival analyses estimated time-space variation in fe-
male to male odds ratios of these disorders across co-
horts defined by the following age ranges: 18 to 34, 35
to 49, 50 to 64, and 65 years and older. Structural equa-
tion analysis examined predictive effects of variation in
gender role traditionality on these odds ratios.
Results: In all cohorts and countries, women had more
anxiety and mood disorders than men, and men had more
externalizing and substance disorders than women. Al-
though gender differences were generally consistent across
cohorts, significant narrowing was found in recent co-
horts for major depressive disorder and substance dis-
orders. This narrowing was significantly related to tem-
poral (major depressive disorder) and spatial (substance
disorders) variation in gender role traditionality.
Conclusions: While gender differences in most life-
time mental disorders were fairly stable over the time-
space units studied, substantial intercohort narrowing of
differences in major depression was found to be related
to changes in the traditionality of female gender roles.
Additional research is needed to understand why this tem-
poral narrowing was confined to major depression.
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E PIDEMIOLOGICAL SURVEYShave consistently docu-mented significantly higherrates of anxiety and mooddisorders among women
than men1,2 and significantly higher rates of
externalizing and substance use disorders
among men than women.3-5 Although a
number of biologic, psychosocial, and
biopsychosocial hypotheses have been
proposed to account for these patterns,6-8
evidence that gender differences in depres-
sion9,10 and substance use11-13 have nar-
rowed in a number of countries has led to
a special interest in the gender roles hy-
pothesis. This hypothesis asserts that gen-
der differences in the prevalence of mental
disorders are due to differences in the typi-
cal stressors, coping resources, and oppor-
tunity structures for expressing psycho-
logic distress made available differentially
to women and men in different countries
at different points throughout history.14,15
Consistent with this hypothesis, evidence
of decreasing gender differences in depres-
sion and substance use has been found
largely in countries in which the roles of
women have improved in terms of oppor-
tunities for employment, access to birth con-
trol, and other indicators of increasing gen-
Author Affiliations are listed at
the end of this article.
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der equality, while trend studies in countries in which
gender roles have been more static11,16 or during historical
periods when gender role changes have been small17 have
failed to document a reduction in gender differences in de-
pression or substance use.
Most research aimed at investigating the gender roles
hypothesis has focused on individual-level variation in
roles in a single country at a single time.18-20 This ap-
proach is limited in 3 ways. First, selection bias for roles
owing to preexisting mental illness (eg, women with ago-
raphobia having a higher probability than other women
of becoming homemakers rather than seeking employ-
ment outside the home) confounds attempts to evaluate
the causal effects of gender roles. Second, gender differ-
ences are largely confined to differences in lifetime risk,
with much less evidence for gender differences in re-
cent prevalence among lifetime cases.21 This means that
investigation of the determinants of gender differences
should focus on lifetime first onset of disease rather than
on the recent prevalence that has been the focus of most
studies. Third, because the gender roles hypothesis is one
about the effects of social context, a rigorous test of the
hypothesis requires an analysis of societal-level, time-
space variation rather than the individual-level varia-
tion that has been the focus of most studies.
A small number of cross-national comparative studies
have examined spatial variation in gender differences in de-
pression22 and alcohol abuse13 at 1 point or, more rarely,
at 2 points.11 Although these studies raised the possibility
that gender roles might be associated with variation in the
magnitude of gender differences in these outcomes, they
were unable to test this hypothesis owing to the small num-
ber of cross-sectional country-level observations included
in the analyses. Our article provides a more direct test of
the gender roles hypothesis by analyzing community epi-
demiological data collected from respondents surveyed in
15countries aspartof theWorldHealthOrganizationWorld
Mental Health (WMH) Survey Initiative.21 Previous cross-
national comparisons of gender differences in mental ill-
ness focused on cross-sectional differences. We, in com-
parison, use retrospective reports obtained in the WMH
surveys about lifetime occurrence and age at onset of men-
tal disorders in different birth cohorts to study time-space
variation in lifetime risk. Specifically, we examine both varia-
tion across cohorts within a single country (temporal varia-
tion) and variation across countries within a single cohort
(spacial variation) in lifetime risk of mental disorders as a
function of time-space variation in the traditionality of gen-
der roles. We focused on lifetime risk rather than recent
prevalence, though accuracy of reporting is doubtlessly bet-
ter for recent episodes than lifetime occurrence, to ad-
dress the fact that gender differences in lifetime risk are
much more robust than those in current prevalence among
lifetime cases.
METHODS
STUDY SAMPLE
World Mental Health surveys were carried out in samples of
adults (age 18 years) in 5 countries classified by the World
Bank23 as developing (Colombia, Lebanon, Mexico, South Africa,
and Ukraine) and 10 classified as developed (Belgium, France,
Germany, Israel, Italy, Japan, the Netherlands, New Zealand,
Spain, and the United States). The total sample size was 72 933
individuals. Individual country samples ranged from 2372 (the
Netherlands) to 12 790 (New Zealand) (Table1). The weighted
average response rate was 71.2%. Country-specific response rates
ranged from 45.9% (France) to 87.7% (Colombia). All sur-
veys were based on probability household samples either re-
gionally representative (Colombia, Japan, and Mexico) or na-
tionally representative (all other countries). Survey sample
characteristics are described in more detail elsewhere.24
All interviews were conducted face-to-face by trained lay in-
terviewers. Each interview had 2 parts. All respondents com-
pleted part I, which contained assessments of core mental dis-
orders; all part I respondents who met criteria for any core
disorder plus a probability subsample of approximately 25%
of other part I respondents were administered part II. Part II
assessed correlates, service use, and disorders of secondary in-
terest. The part II data, used in the current article, were weighted
to adjust for oversampling part I respondents with mental dis-
orders and for differential probabilities of selection within house-
holds (owing to only 1 household member, and in some cases
2, being surveyed in each household no matter the number of
adults residing there) and to match sample distributions to popu-
lation sociodemographic distributions. Standardized inter-
viewer training procedures, translation and back-translation pro-
cedures, and quality-control procedures were applied across all
WMH countries to ensure comparability. Informed consent was
obtained in all countries. These procedures are described in more
detail elsewhere.24,25
DSM-IV DISORDERS
Mental disorders were assessed with version 3.0 of the World
Health Organization Composite International Diagnostic In-
terview (CIDI),26 a fully structured diagnostic interview. Trans-
lation, back-translation, and harmonization of the interview to
local languages with the original English version of CIDI were
carried out in each WMH country using World Health Orga-
nization guidelines.27 Disorders were assessed using DSM-IV
definitions.28 Disorders assessed included mood disorders (ma-
jor depressive disorder [MDD], dysthymic disorder, and bipo-
lar disorder), anxiety disorders (panic disorder, generalized anxi-
ety disorder, agoraphobia without panic disorder, social phobia,
specific phobia, separation anxiety disorder, and posttrau-
matic stress disorder), externalizing disorders (attention-deficit/
hyperactivity disorder, conduct disorder, intermittent explo-
sive disorder, and oppositional defiant disorder), and substance
disorders (alcohol and illicit drug abuse with or without de-
pendence). The DSM-IV organic exclusion rules were used to
make diagnoses.
Methodological evidence collected in clinical reappraisal stud-
ies show that diagnoses of anxiety, mood, and substance disor-
ders based on CIDI have generally good concordance (25th-
75th percentiles of area under the receiver operating characteristic
curve equal to 0.71-0.81), with diagnoses based on blinded clini-
cal reappraisal interviews.29 No evaluations were made of test-
retest reliability. The evidence regarding good concordance with
clinical diagnoses is based on surveys that have been carried out
in only a small number of countries. It is not clear that transla-
tions of the instrument in all countries yield data that would have
the same good concordance with blinded clinical reappraisal in-
terviews. In addition, the externalizing disorder diagnoses were
not validated in the CIDI clinical reappraisal studies, because the
clinical interview that was used as the gold standard in these stud-
ies did not assess externalizing disorders. However, a subse-
quent independent clinical calibration study documented good
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Table 1. WMH Survey Sample Characteristics
Country Survey Sample Characteristicsa
Survey
Year
Age
Range,
y
Sample Size
Response
Rate, %cPart I Part II
Part II and
Age 44 yb
Developed Countries
Belgium ESEMeD NR, stratified, multistage clustered probability
sample of individuals in households from
the national register of Belgium residents
2001-2002 18 2419 1043 486 50.6
France ESEMeD NR, stratified, multistage clustered sample of
working telephone numbers merged with a
reverse directory (for listed numbers).
Initial recruitment was by telephone, with
supplemental in-person recruitment in
households with listed numbers
2001-2002 18 2894 1436 727 45.9
Germany ESEMeD NR, stratified, multistage clustered probability
sample of individuals from community
resident registries
2002-2003 18 3555 1323 621 57.8
Israel NHS Stratified, multistage clustered-area
probability sample of individuals from a
national resident registry
2002-2004 21 4859 72.6
Italy ESEMeD NR, stratified, multistage clustered probability
sample of individuals from municipality
resident registries
2001-2002 18 4712 1779 853 71.3
Japan WMHJ
2002-2003
Unclustered 2-stage probability sample of
individuals residing in households in 4
metropolitan areas (Fukiage, Kushikino,
Nagasaki, and Okayama)
2002-2003 20 2436 887 282 56.4
The Netherlands ESEMeD NR, stratified, multistage clustered probability
sample of individuals in households listed
in municipal postal registries
2002-2003 18 2372 1094 516 56.4
New Zealand NZMHS NR, stratified, multistage clustered-area
probability sample of household residents
2004-2005 18 12 790 7312 4119 73.3
Spain ESEMeD NR, stratified, multistage clustered-area
probability sample of household residents
2001-2002 18 5473 2121 960 78.6
United States NCS-R NR, stratified multistage clustered-area
probability sample of household residents
2002-2003 18 9282 5692 3197 70.9
Developing Countries
Colombia NSMH Stratified multistage clustered-area probability
sample of household residents in all urban
areas of the country (approximately 73% of
the total national population)
2003 18-65 4426 2381 1731 87.7
Lebanon LEBANON NR, stratified, multistage clustered-area
probability sample of household residents
2002-2003 18 2857 1031 595 70.0
Mexico M-NCS Stratified multistage clustered-area probability
sample of household residents in all urban
areas of the country (approximately 75% of
the total national population)
2001-2002 18-65 5782 2362 1736 76.6
South Africa SASH NR, stratified, multistage clustered-area
probability sample of household residents
2003-2004 18 4351 87.1
Ukraine CMDPSD NR, stratified, multistage clustered-area
probability sample of household residents
2002 18 4725 1720 541 78.3
Abbreviations: CMDPSD, Comorbid Mental Disorders During Periods of Social Disruption; ESEMeD, European Study of the Epidemiology of Mental Disorders;
LEBANON, Lebanese Evaluation of the Burden of Ailments and Needs of the Nation; M-NCS, Mexico National Comorbidity Survey; NCS-R, National Comorbidity
Survey Replication; NHS, National Health Survey; NR, nationally representative; NSMH, National Study of Mental Health; NZMHS, New Zealand Mental Health
Survey; SASH, South Africa Health Survey; WMH, World Health Organization World Mental Health; WMHJ 2002-2003, World Mental Health Japan Survey.
aMost WMH surveys are based on stratified, multistage clustered-area probability household samples in which samples of areas equivalent to counties or
municipalities in the United States were selected in the first stage followed by 1 or more subsequent stages of geographic sampling (eg, towns within counties,
blocks within towns, and households within blocks) to arrive at a sample of households, from which a listing of household members was created; 1 or 2 people
were selected from this listing to be interviewed. No substitution was allowed when the originally sampled resident could not be interviewed. These household
samples were selected from census area data in all countries except for France (where telephone directories were used to select households) and the Netherlands
(where postal registries were used to select households). Several WMH surveys (Belgium, Germany, and Italy) used municipal resident registries to select
respondents without listing households. The Japanese sample is the only totally unclustered sample, with households randomly selected in each of the 4 sample
areas and 1 random respondent selected in each sample household. Twelve of the 15 surveys are based on NR household samples, while 2 others are based on
nationally representative household samples in urbanized areas (Colombia and Mexico).
bAll countries with the exception of Ukraine (which was restricted to age 39 years) were restricted to age 44 years and younger.
cThe response rate is calculated as the ratio of the number of households in which an interview was completed to the number of households originally sampled,
excluding from the denominator households known not to be eligible either because of being vacant at the time of initial contact or because the residents could
not speak the designated languages of the survey. The weighted average response rate is 71.2%.
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concordance between diagnoses of adult attention-deficit/
hyperactivity disorder based on CIDI and those based on blinded
clinical reappraisal interviews.30 Another problem exists with the
diagnoses of substance dependence, which was assessed only
among respondents who had a history of abuse. This means that
cases of dependence without abuse are excluded. However, em-
pirical studies in the United States have shown that the number
of cases of dependence without a history of abuse is small and
that their exclusion does not have a substantively meaningful
effect on the estimated associations of predictors with the out-
comes.31-33 Nonetheless, because of this exclusion, we focus herein
on abuse rather than dependence. Retrospective reports of age
at onset were obtained with the CIDI using a series of questions
designed to avoid the implausible response patterns obtained in
reply to a simple question asking for recall of age at first episode
of a focal disorder.34
GENDER ROLE TRADITIONALITY
Each respondent was classified as being in 1 of 4 birth cohorts
defined by age at interview (18-34, 35-49, 50-64, and65 years)
to distinguish broad life-course stages (early adulthood, early
midlife, late midlife, and old age, respectively). Four within-
cohort indicators of female gender role traditionality were cal-
culated in each of the 58 resulting time-space subsamples (4
cohorts in each of 15 countries, minus the 2 oldest cohorts in
Colombia and Mexico owing to an upper age limit of 64 years
in those 2 surveys). The 4 indicators were (1) the ratio of the
proportion of women to men in the cohort who had labor force
experience before age 35 years (extrapolated using survival analy-
sis in the 18- to 34-year-old cohort and calculated directly in
the older cohorts); (2) the ratio of the proportion of women to
men in the cohort who achieved the median level of education
found among workers in the upper quartile of the income dis-
tribution in the cohort; (3) the ratio of the median ages of mar-
riage of women vs men in the cohort; and (4) the proportion
of women in the cohort who used birth control pills or other
medical forms of contraception before age 25 years (restricted
to women aged 25-34 years in the 18- to 34-year-old cohort).
Wemakenoclaimthat these indicators formanexhaustive set
of defining characteristics of gender role traditionality or that the
cutoffs used to construct the measures (eg, labor force participa-
tion by age 34 years rather than some other age we might have se-
lected) are optimal. Rather, the indicators were constructed from
theWMHsurveydataonanadhocbasis tooperationalize aspects
of gender roles that we considered important based on our read-
ing of the demographic literature on gender roles.35-37
Confirmatory factor analysis carried out at the level of the time-
space unit (n=58) showed that our initial thinking in selecting
the 4 indicators was correct in the sense that a strong single-
factor structure was found among these 4 indicators, with factor
loadings in the range of 0.59 to 0.91. (Detailed results showing
the values of each gender role traditionality indicator for each time-
space unit, the correlation matrix among the indicators, and fac-
tor loadings are available from the corresponding author on re-
quest.) This finding confirmed that the indicators are, in fact,
strongly related and can be used to construct a composite mea-
sure that we interpret as a measure of gender role traditionality.
This is the key predictor variable in the analysis we will describe.
Rather than use the ad hoc gender role traditionality mea-
sure described previously, it would have been preferable to ob-
tain objective administrative data on country-level trends in in-
dicators of gender role traditionality. Our attempts to obtain such
data, though, were unsuccessful because of sparse historical data
on these indicators in most countries. The Global Economic Fo-
rum collected country-level data of this sort to assess the socio-
economic-political positions of women in 58 countries in the year
2000,38 but they, like us, were unable to obtain retrospective trend
data. The goal of the Global Economic Forum was to create a base-
line measure that could be used to track the United Nations Mil-
lennium Development Goals of gender equality in social, eco-
nomic, and political functioning (http://www.un.org
/millenniumgoals/). The Global Economic Forum report
constructed a country-level gender empowerment measure (GEM)
for this purpose, which summarized objective data on the eco-
nomic opportunity and participation of women in each country
along with data on female political empowerment, educational
attainment, life expectancy, and access to health care (legal birth
control and legal abortion). The GEM could be developed for only
58 countries because of missing data in the others. The GEM scores
are unavailable for 2 WMH countries (Lebanon and Ukraine). Be-
cause the GEM measure was developed only for the year 2000,
we could not use it to study within-country changes in gender
equality over time. However, we were able to compare scores on
the composite WMH gender role traditionality measure with GEM
scores for the 13 WMH countries for which they were available
to validate our survey-based measure against the gold standard
GEM measure. The Pearson correlation between the 2 measures
was found to be 0.78. This high correlation strongly suggests that
our gender role traditionality measure validly assesses the tradi-
tionality of women’s roles in the WMH countries.
STATISTICAL ANALYSIS
Gender differences in lifetime risk of each disorder were ex-
amined using discrete time survival analysis with person-
years as the unit of analysis.39 This is a method that takes into
consideration age at onset of the disorder in examining pre-
dictors, making it possible to study the predictors of lifetime
occurrence of the disorder among respondents who vary by age.
Each year in the life of each respondent up to and including
the age at onset of the focal disorder (or, in the case of respon-
dents who never had the disorder, up to his or her age at in-
terview) was treated as a separate observational record in this
analysis, with the year at first onset coded 1 on a dichotomous
outcome variable and earlier years coded 0. Years after first on-
set were excluded from the data file. Logistic regression was
used to analyze these data, with gender (coded 1 for women, 0
for men), cohort (coded into the 4 categories as noted), and
person-years (age at the time of the person-year observational
record) included as predictors of first onset of the disorder. The
logistic regression coefficients and their standard errors were
exponentiated to create odds ratios (ORs) and 95% confi-
dence intervals for ease of interpretation. Female to male (F:M)
ORs are the main focus of attention.
A separate model was estimated for each DSM-IV and CIDI
disorder separately in each country. These models were also
estimated in a data file that combined observations across all
countries. The cross-national models included 14 dummy
predictor variables to distinguish among the 15 countries in
addition to the other predictors. The basic models were elabo-
rated to consider possible nonlinear effects of cohort and person-
year (using polynomials and dummy variables to define ranges
on these continuous variables) and to assess whether the gen-
der difference in lifetime risks of the disorders varied by co-
hort, life-course phase, or country. Gender differences were for
the most part consistent across the life course, so these results
are not reported herein but are available on request. The mod-
els were then estimated a final time in the subsample of person-
years in the age range of 1 to 34 years (up to the oldest age in
the youngest grouped cohort subsample) to remove the asso-
ciation between cohort and age in the person-year data file.
In cases for which the survival analysis documented sig-
nificant time-space variation in the gender difference for a
particular outcome, structural equation models using the 58
time-space subsamples as the unit of analysis estimated the
extent to which a latent measure of gender role traditionality
(defined in terms of the 4 indicators described) could
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account for this variation. The best-fitting model was deter-
mined as that with the lowest value on the Bayesian informa-
tion criterion,40 a standard measure of model fit. Structural
equation models are regression models that estimate coeffi-
cients simultaneously across a series of equations, some of
which can include presumed latent (not directly measured)
variables that are assumed to have a prespecified relation-
ship to measured variables, in an effort to maximize the fit
between predicted and observed matrices of covariation
among the observed variables. In our case, the structural
equation models assumed that time-space variation in a
latent measure of gender role traditionality predicted time-
space variation in the F:M ORs of disorders that were found
to have significant time-space variation.
Survival coefficients and their standard errors were esti-
mated using the Taylor series linearization method41 in the
SUDAAN software system.42 Multivariate tests of the signifi-
cance of interactions involving gender with person-year, co-
hort, and country were made with Wald 2 tests using Taylor
series design-based coefficient variance-covariance matrices. In
the case of cross-national models, a single variable that as-
signed a unique value to each sampling stratum in each coun-
try was created, while a second variable that distinguished sam-
pling-error calculation units within each stratum was created.
These 2 variables were used as the input to SUDAAN to cal-
culate design-based estimates. Structural equation models were
calculated using the Mplus software system.43 Significance tests
of regression coefficients in the structural equation models were
estimated using the standard errors generated by Mplus, which
assumed that the 58 time-space observations represented a
simple random sample from a larger universe of such units.
P .05 (2-sided) was considered significant.
RESULTS
GENDER DIFFERENCES IN LIFETIME RISKS
OF MENTAL DISORDERS
Results are highly consistent across countries in show-
ing that women have a significantly higher lifetime risk
of most mood disorders (MDD and dysthymic disorder)
and all anxiety disorders than men (Table2). The pooled
F:M ORs for these disorders are all statistically signifi-
cant and range from 1.3 to 2.6. Within-country ORs for
these disorders are also consistently greater than 1.0. The
one exception to this general pattern is bipolar disor-
Table 2. Associations of Gender With Lifetime Risk of DSM-IV Mental Disorders in the WMH Surveys (N=72 933)a
Mental Disorder
No. of
Subjectsb
All-Country F:M
OR (95% CI)
Within-Country OR Variation
Range %
GenderCountry
Interaction, 2cMin Max
Dominant
Direction
P .05 in Dominant
Direction
Mood disorders
Major depressive disorder 15 1.9 (1.8-2.0)d 1.6 2.4 100.0 100.0 29.3d
Dysthymic disorder 10 1.9 (1.6-2.2)d 1.3 3.8 100.0 70.0 13.0
Bipolar disorder 6 0.9 (0.8-1.0) 0.6 1.1 83.3 20.0 8.1
Any mood disorder 15 1.8 (1.7-1.8)d 1.5 2.5 100.0 100.0 47.7d
Anxiety disorders
Panic disorder 12 1.9 (1.7-2.2)d 1.2 3.4 100.0 66.7 15.8
Generalized anxiety disorder 15 1.7 (1.5-1.9)d 0.7 2.7 86.7 76.9 23.7d
Agoraphobia 8 2.0 (1.7-2.3)d 1.4 4.6 100.0 62.5 18.5
Social phobia 13 1.3 (1.2-1.4)d 1.1 2.0 100.0 46.2 13.8
Specific phobia 12 2.0 (1.9-2.2)d 1.3 3.1 100.0 100.0 39.3d
Separation anxiety disorder 4 1.6 (1.4-1.8)d 1.4 2.0 100.0 75.0 3.8
Posttraumatic stress disorder 14 2.6 (2.2-2.9)d 1.3 6.4 100.0 78.6 30.6d
Any anxiety disorder 15 1.7 (1.6-1.8)d 1.2 3.2 100.0 86.7 41.2d
Externalizing disorders
Attention-deficit/hyperactivity disorder 5 0.6 (0.5-0.8)d 0.3 0.6 100.0 20.0 6.9
Conduct disorder 3 0.5 (0.4-0.7)d 0.3 0.6 100.0 100.0 29.5d
Intermittent explosive disorder 6 0.7 (0.6-0.8)d 0.4 0.8 100.0 33.3 5.3
Oppositional defiant disorder 3 0.8 (0.6-1.0)d 0.5 0.8 100.0 33.3 18.2d
Any externalizing disorder 12 0.7 (0.6-0.8)d 0.3 1.4 83.3 40.0 7.2
Substance disorders
Alcohol abuse 15 0.2 (0.2-0.3)d 0.1 0.4 100.0 100.0 128.6d
Alcohol dependence 11 0.3 (0.3-0.4)d 0.1 0.4 100.0 100.0 95.6d
Drug abuse or dependence 5 0.4 (0.3-0.4)d 0.1 0.4 100.0 100.0 35.3d
Any substance disorder 14 0.3 (0.2-0.3)d 0.1 0.4 100.0 100.0 141.6d
Any disorder 15 1.1 (1.1-1.2)d 0.7 2.2 66.7 70.0 111.5d
Abbreviations: CI, confidence interval; F:M, female to male; Max, maximum; Min, minimum; OR, odds ratio; WMH, World Health Organization World Mental
Health.
aBased on discrete time survival models that used respondent cohort (age at interview), sex, and person-year to predict first onset of each disorder both
separately in each country and pooled across all countries.
bThe number of countries differs across outcomes because not all disorders were assessed in all countries. The pooled results for any mood disorder, any
anxiety disorder, any externalizing disorder, and any substance disorder pooled whatever disorders in the relevant category existed in the country across countries
though the set sometimes differed across countries.
cBased on the pooled cross-national survival model that included an interaction between gender and the dummy variables for country.
dSignificant at P .05, 2-sided.
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der, for which the pooled OR is not statistically signifi-
cant (OR, 0.9). Results are the opposite for most exter-
nalizing disorders (attention-deficit/hyperactivity disorder,
conduct disorder, and intermittent explosive disorder)
and all substance disorders. The pooled F:M ORs for these
disorders are all statistically significant and less than 1.0
(range, 0.3-0.8), indicating significantly higher risk among
men than women. Within-country ORs for these disor-
ders are also always less than 1.0. Despite their consis-
tent direction, the magnitudes of the ORs vary signifi-
cantly across countries for many of the disorders studied.
INTERCOHORT VARIATION
Gender differences in lifetime risk for most disorders do
not differ significantly across cohorts (Table 3). How-
ever, there are 3 notable exceptions. The first involves
MDD, which has a pooled OR for the gendercohort in-
teraction across countries of 0.88 (95% confidence in-
terval, 0.82-0.95). This means that the higher odds among
women than men are less pronounced in more recent co-
horts. This general pattern is found in 11 of the 15 coun-
tries. The second exception involves intermittent explo-
sive disorder, in which the pooled gendercohort OR
across countries is 1.26 (95% confidence interval, 1.07-
1.48). This means that the higher odds among men than
women are less pronounced in more recent cohorts. This
general pattern is found in 5 of the 6 countries that as-
sessed intermittent explosive disorder. The third in-
volves substance disorders, largely driven by alcohol dis-
orders. The pooled gendercohort OR across countries
in predicting any substance disorder is 1.45 (95% con-
fidence interval, 1.27-1.66). It is important to remem-
ber that any substance disorder is equivalent to either al-
cohol or drug abuse because, as noted in the “DSM-IV
Disorders” section, dependence was assessed only among
respondents with a history of abuse. This means that the
higher odds of a lifetime substance abuse among men than
Table 3. Interactions of Gender With Cohort in Predicting Lifetime Risk of DSM-IV Mental Disorders in the WMH Surveys (N=72 933)a
Mental Disorder
No. of
Subjectsb
All-Country OR
(95% CI)
Within-Country OR Variation
Range %
Min Max
Dominant
Direction
P .05 in Dominant
Direction
Mood disorders
Major depressive disorder 15 0.9 (0.8-1.0)c 0.6 1.1 73.3 36.4
Dysthymic disorder 8 0.9 (0.7-1.1) 0.2 1.5 50.0 25.0
Bipolar disorder 6 1.1 (0.9-1.3) 0.9 2.1 66.7 0.0
Any mood disorder 15 0.9 (0.8-0.9)c 0.6 1.2 60.0 33.3
Anxiety disorders
Panic disorder 12 1.0 (0.8-1.1) 0.3 3.5 58.3 0.0
Generalized anxiety disorder 15 1.1 (1.0-1.2) 0.4 1.7 60.0 11.1
Agoraphobia 8 1.0 (0.8-1.2) 0.7 1.6 50.0 0.0
Social phobia 12 1.0 (0.9-1.1) 0.7 2.3 58.3 14.3
Specific phobia 12 1.0 (0.9-1.1) 0.7 1.2 50.0 16.7
Separation anxiety disorder 4 0.9 (0.7-1.1) 0.7 1.3 50.0 0.0
Posttraumatic stress disorder 14 1.1 (1.0-1.3) 0.4 2.0 57.1 25.0
Any anxiety disorder 15 1.0 (0.9-1.0) 0.7 1.2 53.3 0.0
Externalizing disorders
Attention-deficit/hyperactivity disorder 5 1.0 (0.7-1.5) 0.1 5.9 80.0 0.0
Conduct disorder 3 1.4 (0.8-2.2) 0.1 1.5 66.7 100.0
Intermittent explosive disorder 6 1.3 (1.1-1.5)c 0.4 1.8 83.3 40.0
Oppositional defiant disorder 3 0.9 (0.5-1.6) 0.7 0.9 100.0 0.0
Any externalizing disorder 12 1.1 (0.8-1.4) 0.2 6.5 58.3 28.6
Substance disorders
Alcohol abuse 14 1.5 (1.3-1.7)c 0.7 4.0 85.7 66.7
Alcohol dependence 10 1.5 (1.2-1.8)c 0.8 6.6 90.0 55.6
Drug abuse or dependence 3 1.2 (0.9-1.5) 0.6 1.3 66.7 50.0
Any substance disorder 14 1.4 (1.3-1.7)c 0.7 5.0 85.7 66.7
Any disorder 15 1.0 (0.9-1.0) 0.8 1.7 60.0 0.0
Abbreviations: CI, confidence interval; F:M, female to male; Max, maximum; Min, minimum; OR, odds ratio; WMH, World Health Organization World Mental
Health.
aBased on discrete time survival models that used respondent cohort (age at interview), sex, person-year, and the interaction between sex and cohort to predict
first onset of each disorder both separately in each country and pooled across all countries. Each respondent was classified as being in 1 of 4 cohorts based on
age at interview (18-34, 35-49, 50-64, and 65 years). A continuous variable coded 1 through 4, 1 for the earliest cohorts (ie, aged 65 years at interview) and 4
for the most recent cohorts (ie, aged 18-34 years at interview) was used to create the interaction terms, for which the variable was multiplied by a gender variable
(0-1) (coded 1 for women and 0 for men). An interaction term with an OR significantly greater than 1.0 means that the F:M OR is significantly higher (ie, higher
relative prevalence among women than men) in more recent cohorts, while an OR less than 1.0 means that the F:M OR is significantly lower (ie, lower relative
prevalence among women than men) in more recent cohorts.
bThe number of countries differs across outcomes because not all disorders were assessed in all countries. The pooled results for any mood disorder, any
anxiety disorder, any externalizing disorder, and any substance disorder pooled whatever disorders in the relevant category existed in the country across
countries, though the set sometimes differed across countries.
cSignificant at P .05, 2-sided.
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women are less pronounced in more recent cohorts. This
general pattern is found in 12 of the 14 countries in which
substance abuse was assessed.
TIME-SPACE VARIATION IN GENDER ROLE
TRADITIONALITY AND F:M ORs
The remaining analyses focused on MDD and substance
disorders, the disorders associated with significant in-
tercohort variation in the F:M ORs across most coun-
tries. (Intermittent explosive disorder was excluded be-
cause it was assessed in only 6 WMH countries, yielding
too few time-space units for stable analysis.) Before de-
scribing the results, it is instructive to examine the raw
data on time-space variation in the composite measure
of gender role traditionality, created by averaging stan-
dardized scores on the 4 indicators (Table 4). A gen-
erally monotonic decrease in traditionality can be seen
across successively more recent cohorts in each coun-
try. All but 2 countries (New Zealand and Ukraine) had
levels above the mean in gender role traditionality at the
time respondents in the oldest cohorts reached early adult-
hood. All but 2 countries had levels below the mean and
the other 2 (Italy and Lebanon) were very close to the
mean gender role traditionality in comparison by the time
respondents in the most recent cohorts entered early adult-
hood. Lebanon had by far the highest traditionality score
in each cohort, but the other countries with high gender
role traditionality scores in the oldest cohorts were all
developed countries either in southern Europe (Italy and
Spain) or Asia (Japan). Three of these 4 countries (Ja-
pan, Lebanon, and Spain) had the most dramatic de-
creases in gender role traditionality over time, along with
Belgium and the Netherlands.
A number of structural equation models were fit to
examine the associations of this time-space variation
in gender role traditionality with the F:M ORs in MDD
and substance disorder. (Detailed results are available
from the corresponding author on request.) The final
model (Figure) defines gender role traditionality as a
standardized (to a mean of 0 and variance of 1) latent
variable indicated by our 4 observed measures, in
which gender role traditionality is a predictor of the
F:M ORs of MDD and any substance disorder. The 4
measured indicators are assumed to have effects on
these outcomes only through gender role traditional-
ity. High gender role traditionality score is signifi-
cantly associated with an increase of 0.38 SDs in the
F:M OR for MDD (the high prevalence of MDD in
women decreases as female gender roles become less
traditional) and with a decrease of 0.46 SD in the F:M
OR for any substance disorder (ie, women begin to
“catch up” to men in their rates of substance disorders
as female gender roles become less traditional).
Because all coefficients in the model are standard-
ized (the measures are transformed to have a mean of 0
and a variance of 1), it is necessary to consider the sub-
stantive meaning of a standard deviation for each mea-
sure to put the results into meaningful terms. Beginning
with the gender role traditionality indicators, a 1-SD de-
crease in gender role traditionality would be equivalent
to changing the F:M ratio of labor force participation from
the sample-wide mean of 0.85 (women were about 15%
less likely than men to be in the labor force) to 1.0 (women
and men were equally likely to be in the labor force),
changing the F:M ratio of high educational attainment
from the mean of 0.84 (women were 16% less likely than
men to obtain high education) to 1.03 (rough gender
equality), changing the older age at marriage of men than
women from the mean of 3.2 years to 2.2 years, and chang-
ing the proportion of young women using birth control
from the mean of 37.5% to 69.4%.
As noted above, a decrease of 1 SD in gender role tra-
ditionality indicators is associated with a decrease in the
F:M OR of MDD of 0.38 SD and an increase in the F:M
OR of any substance disorder of 0.46 SD. We need to know
the means and standard deviations of the outcomes in
the unweighted sample of 58 time-space units to make
substantive sense of these effect size estimates. The mean
values are 2.61 (SD, 1.81) for MDD and 0.17 (SD, 0.14)
for any substance disorder. Therefore, changes of 1 SD
in the gender role traditionality indicators are associ-
ated with a reduction in the F:M OR for MDD from the
mean of 2.6 to 1.9 (a reduction of nearly 45% in the el-
evated F:M OR) and with an increase in the F:M OR of
any substance disorder from the mean of 0.17 to 0.25 (a
reduction of nearly 30% in the elevated M:F OR).
Although variations due to time and space were
combined in the structural equation analysis, it is pos-
sible to separate the 2 components by introducing
dummy variable controls in the model either for
cohort (time) or for country (space) (Table 5). When
this is done, we see that the association between gen-
Table 4. Distribution of the Standardized Gender Role
Traditionality Composite Measure Across the WMH
Countries and Cohortsa
Country
Gender Role Traditionality Score
by Age Cohort
18-34 y 35-49 y 50-64 y 65 y
Developed countries
Belgium −3.7 −2.8 0.9 2.7
France −3.5 −2.5 −0.7 0.9
Germany −3.4 −3.4 0.9 1.6
Israel −2.4 −0.4 −0.3 0.7
Italy 0.2 1.2 2.9 4.8
Japan −4.4 0.1 −1.2 3.1
The Netherlands −5.1 −0.2 −1.9 1.7
New Zealand −2.2 −0.9 −1.3 −1.3
Spain −4.0 −0.7 3.3 3.4
United States −3.5 −3.1 −2.3 2.0
Developing countries
Colombia −0.5 1.2 2.0
Lebanon 0.2 4.4 8.3 8.3
Mexico −0.6 2.0 3.1
South Africa −0.8 1.1 1.2 2.2
Ukraine −2.1 −4.8 0.2 −1.0
Abbreviation: WMH, World Health Organization World Mental Health.
aEach indicator was standardized to have a mean of 0 and a variance of
1.0 across the sample of 58 time-space units. Each time-space unit was
assigned equal weight in calculating the mean and variance. The composite
was then created by summing the 4 standardized indicator scores and then
standardizing the sum to have a mean of 0 and a variance of 1.0 across the
sample of 58 time-space units.
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der role traditionality and the F:M OR for MDD is
entirely due to between-cohort variation within coun-
tries, while the association between gender role tradi-
tionality and the F:M OR for any substance disorder is
largely due to within-cohort variation across coun-
tries. It is consequently only the association involving
MDD that involves intercohort changes within coun-
tries. We also investigated the possibility that the
results are sensitive to extreme values in a small num-
ber of countries by replicating the Table 5 results 15
times, each time deleting the data from 1 country.
(Detailed results are available from the corresponding
author on request.) The only case in which a meaning-
ful change in the model coefficients occurred was
when we deleted Lebanon, but even in this case the
coefficients remained statistically significant and
strong in substantive terms. This result demonstrates
that the overall study results are not highly sensitive to
individual outlier countries.
COMMENT
Several methodological limitations need to be noted in
interpreting the WMH results. First, the response rates
were lower in developed than developing countries and
might have been related to gender role traditionality, pos-
sibly introducing bias into the results. We weighted the
data in each country for differential nonresponse by cen-
sus sociodemographic variables, but there is no guaran-
tee that this corrected for biases introduced by incom-
plete responses. Second, the surveys also differed across
countries in other ways, such as the language in which
they were administered and the extent to which each
country had a tradition of independent public opinion
research, which would have allowed respondents to see
the survey as a normal undertaking; this might have af-
fected results. Third, diagnoses were based on fully struc-
tured interviews administered by lay interviewers rather
than on clinician-administered semi-structured inter-
views. This limitation is somewhat reduced by the fact
that WMH clinical reappraisal studies documented gen-
erally good concordance between the diagnoses based on
the CIDIs and diagnoses based on blinded semi-
structured clinical reappraisal interviews.29 However, as
noted in the section on measures, the diagnoses of ex-
ternalizing disorders were not validated and might be less
accurate than those of other disorders. The substance de-
pendence diagnoses had the additional problem of ex-
cluding cases of dependence without a history of abuse.
The results concerning the broadly defined measures of
substance disorders should consequently be interpreted
as applying to abuse rather than to dependence. As noted
in the section on measures, however, empirical studies
have shown that the number of cases of substance de-
pendence without a history of abuse is small in the United
States and that their exclusion does not meaningfully affect
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Figure. Standardized parameter estimate of the association between time-space variation in gender role traditionality and the female to male odds ratios of lifetime
DSM-IV major depressive disorder (MDD) and substance abuse/dependence (SAD) in the 58 WMH cohort by country time-space subsamples. Observed variables
and gender role traditionality [GRT] are all standardized to a mean of 0.0 and a standardized deviation of 1.0. Bc indicates percentage of women using birth control
before the age of 25 years; Ed, female to male percentage reaching the median education level of the top quartile of earners; Lf, female to male percentage in labor
force by age 35 years; Ma, female to male median age at first marriage; *significant at P .05, 2-sided.
Table 5. Associations of Gender Role Traditionality
With First Onset of Major Depressive Disorder
and Any Substance Disorder
Control
Standardized Regression Coefficient
Linking Gender Role Traditionality
With Disorder (SE)
Major Depressive
Disorder
Any Substance
Disorder
None 0.38 (0.19)a,b −0.46 (0.19)a,b
Temporal variation 0.06 (0.20) −0.44 (0.21)b
Spatial variation 0.60 (0.24)b −0.20 (0.18)
Abbreviation: SE, standard error.
aCoefficients presented in the Figure.
bSignificant at P .05, 2-sided.
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the size of the coefficients between predictors and mea-
sures of substance disorders. Fourth, lifetime preva-
lence and age at onset were assessed with retrospective
reports, which could be systematically biased.44 We used
an innovative probing method designed to minimize re-
call bias,34 but bias may still have been introduced by age-
related gender differences either in memory failure, men-
tal health awareness, or willingness to admit emotional
problems to an interviewer. Fifth, the analysis of gender
differences in lifetime risk across cohorts could be bi-
ased if the increasing attrition with age in older cohorts
is differentially related to history of mental disorders
among women vs men. Sixth, the indicators of female gen-
der role traditionality were few and might not have cap-
tured all the dimensions of female gender roles that are
important for explaining secular trends in the F:M ORs.
Furthermore, the indicators we used might be related to
constructs other than gender role traditionality. How-
ever, these concerns are reduced because our composite
gender role traditionality measure correlates very strongly
with an independent measure of gender empowerment
based on objective administrative data assembled by the
Global Economic Forum.
Within the context of these limitations, our article is the
first to present the results of a quantitative examination of
time-space variation in the association between female gen-
der role traditionality and gender differences in mental ill-
ness. We found that the frequently observed gender dif-
ferences in anxiety, mood, externalizing, and substance
disorders have remained relatively stable during the more
than half century separating respondents in the youngest
and oldest WMH cohorts despite the unprecedented
changes in female gender roles that occurred during this
period. Furthermore, we found that aggregate F:M ORs are
relatively consistent across countries despite substantial be-
tween-country variation in female gender role traditional-
ity. These patterns argue against the claim that changes in
gender roles play an important role in bringing about re-
ductions in gender differences in the lifetime risk of most
mental disorders.
The only notable exceptions to this general pattern con-
cern major depression, intermittent explosive disorder,
and substance disorders, in which gender differences were
found to be significantly smaller in more recent co-
horts. As noted in the introduction, evidence consistent
with this narrowing has been found in several within-
country studies of gender differences in MDD,9,10,45 sub-
stance use disorders,11 and substance disorders,46-48 while
other studies have documented cross-national variation
in gender differences at specific points.13,22 However, no
previous study combined the 2 types of comparisons to
study time-space variation while linking independent mea-
sures of gender role traditionality to data on variation in
gender differences over time or in space.
In the case of MDD, the gender roles hypothesis would
interpret our findings as meaning that increases in fe-
male opportunities in the domains of employment, birth
control, and other indicators of increasing gender role
equality promote improvements in female mental health
by reducing exposure to stressors that can lead to de-
pression and by increasing access to effective stress-
buffering resources.15,49 However, it is important to ac-
knowledge that we did not directly evaluate the validity
of this hypothesis. We documented that gender differ-
ences in the risk of MDD onset are significantly nar-
rower for times and places in which the roles of women
are more equal to those of men, but we did not measure
time-space variation in stress exposure or stress reactiv-
ity to see if the latter mediates the predictive effects of
gender role traditionality. These more specific analyses
go beyond the limits of the WMH data but should be the
subject of future studies.
In the case of substance disorders, the gender roles hy-
pothesis takes a somewhat different form by arguing that
opportunities for female substance use and attitudes about
the appropriateness of female substance use both change
as female roles become more similar to male roles, result-
ing in an increase in female substance use.14,50,51 Consis-
tent with this hypothesis, cross-national research has docu-
mented that current female drinking behaviors are more
similar to those in males in countries in which gender roles
are more equal,52,53 though results have not been entirely
consistent.54 However, these previous studies did not ex-
amine gender differences in lifetime risk of substance dis-
orders, which means that our results can be seen as build-
ing on the findings of these earlier studies.
It is unclear why the WMH findings showed much
stronger evidence for temporal than spatial predictive as-
sociations in MDD and for spatial than temporal asso-
ciations in substance disorders. It is also unclear why the
narrowing of gender differences in recent cohorts was con-
fined to MDD, intermittent explosive disorder, and sub-
stance disorders. It is conceivable that the much younger
ages at onset of most other disorders, especially the anxi-
ety disorders and externalizing disorders, than MDD or
substance disorders make the former disorders less sus-
ceptible than the latter ones to the influences of changes
in adult gender roles. That argument does not extend to
generalized anxiety disorder, though, which has a simi-
lar age at onset distribution to MDD.55 For this reason,
why narrowing occurred for MDD but not generalized
anxiety disorder is especially puzzling. Increased under-
standing of these specifications should be the subject of
future theorizing and empirical investigation.
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